Research and Markets has announced the addition of the "Lymphoma: Analytical Tool" report to their offering.
Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals from a business development, drug development or investment perspective.
It covers more than 384 companies plus partners who are today developing 753 lymphoma drugs where of 568 are active in 1073 developmental projects in cancer across 302 different targets.
The Analytical Tools have proven their worth to our clients in oncology for almost two decades in their capacities covering:
For more information about this report visit http://www.researchandmarkets.com/research/vxnfvf/lymphoma
Related Topics: Hematology
View source version on businesswire.com: http://www.businesswire.com/news/home/20160919005551/en/Business Wire
Last updated on: 19/09/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.